“…TE cells were obtained by an explant technique using TE medium containing 67% DMEM (Life Technologies, Grand Island, NY), 22% Ham's F-12 (Life Technologies), 5% Fetal Clone II serum (HyClone, Logan, UT), 0.4 g/ml hydrocortisone, 5 g/ml insulin, 11 ng/ml recombinant human epidermal growth factor (Collaborative Biomedical, Bedford, MA), 0.18 M adenine, 10 溪10 M cholera toxin (ICN Biomedicals, Aurora, OH), 0.25 g/ml Fungizone, and 50 g/ml gentamicin on mitomycin-C-treated NIH-3T3 fibroblast feeder layers as described (23,24). Contaminating fibroblasts were removed from TE cultures by treatment with 0.02% EDTA in PBS followed by complement-mediated lysis with mAb 1B10, which binds to a cell surface Ag on fibroblasts (25).…”